Blogs

Filling the Tech Gap in Metastatic Breast Cancer Clinical Trials

According to the American Cancer Society (ACS), a woman living in the United States has a 1 in 8 chance of developing breast cancer, the second-leading cause of cancer death in women (behind only lung cancer). Despite advances in treatment, about 30% of women initially diagnosed with early-stage breast cancer will have a recurrence or experience metastatic disease.[i] Moreover, while…

My Journey to AI-driven Clinical Trials

Throughout my two-decade career in the biopharmaceutical industry, my goal has been to make drug development more efficient while reducing costs, and to help the companies I have worked for increase revenue without compromising quality. In pursuing that goal, I have strived to embrace advanced technologies and to optimize organizational and operational structures. Now that I have joined Phesi, I…

Pharma and Biotech are Waiting for 21st Century Clinical Trial Data Analytics Engines

As a repository of clinical trial information, few databases are as trusted – or as widely used – as www.clinicaltrials.gov. A service of the U.S. National Library of Medicine, clinicaltrials.gov aims to provide comprehensive information on privately and publicly funded clinical studies conducted around the world. Many drug developers mine the database to facilitate decisions on trial design, investigator recruitment,…

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.